FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Pantoprazole Sodium for Injection
Status: Currently in Shortage
»Date first posted: 05/28/2019
»Therapeutic Categories: Gastroenterology

Expand all

Eugia Pharma Specialties LTD. (formerly Aurobindo) (Revised 05/16/2022)

Company Contact Information:
888-238-7880

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
40 mg, 10 vials (NDC 55150-202-10) Currently on backorder, next shipment early June Check wholesalers for inventory Demand increase for the drug

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 04/08/2022)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
40 mg, 10 vials (NDC 0143-9284-10) Inventory is currently available. Additional lots are scheduled to be manufactured. Product will be made available as it is released. Demand increase for the drug

Pfizer Pharmaceuticals (Revised 05/10/2022)

Company Contact Information:
800-533-4535

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
40 mg, 10 vials (NDC 0008-0923-55) Available Other
40 mg, 25 vials (NDC 0008-0923-60) Next Delivery: May 2022; Estimated Recovery: February 2023 Shortage per Manufacturer: Manufacturing Delay Other
40 mg, 10 vials (NDC 0008-2001-10; Amerinet) Next Delivery and Estimated Recovery: February 2023 Shortage per Manufacturer: Manufacturing Delay Other
40 mg, 25 vials (NDC 0008-2001-25; Amerinet) Next Delivery and Estimated Recovery: February 2023 Shortage per Manufacturer: Manufacturing Delay Other
40 mg, 10 vials (NDC 0008-4001-10; PremierPro) Available Other
40 mg, 25 vials (NDC 0008-4001-25; PremierPro) Next Delivery: May 2022; Estimated Recovery: February 2023 Shortage per Manufacturer: Manufacturing Delay Other

Sandoz (Reverified 05/19/2022)

Company Contact Information:
800-525-8747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
40 mg, 10 vials (NDC 0781-3232-95) Limited Availability Demand increase for the drug
40 mg, 10 vials (NDC 72572-550-10) Available Marketed by Civica
40 mg, 10 vials (NDC 65219-433-15) Limited availability Marketed by Fresenius Kabi Demand increase for the drug

Sun Pharmaceutical Industries Inc. (Revised 04/05/2022)

Company Contact Information:
800-818-4555

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
40 mg, 10 vials (NDC 62756-129-44) Available Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English